期刊
LIPIDS
卷 50, 期 10, 页码 945-953出版社
WILEY
DOI: 10.1007/s11745-015-4059-z
关键词
Fucoxanthin; Delta-5 desaturase; Elongation; ALA; EPA; DHA; n-3 PUFA
资金
- National Science Council of Taiwan [NSC 99-2313-B-002-013-MY3, NSC 98-2313-B-002-002-MY3]
Dietary fucoxanthin (FX), a carotenoid compound from brown algae, was found to increase docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) in the liver of mice. DHA and ARA are known to be biosynthesized from the respective precursor alpha-linolenic acid (ALA, 18:3n-3) and linoleic acid (LNA, 18:2n-6), through desaturation and chain elongation. We examined the effect of FX on the fatty acid metabolism in HepG2 cells (Hepatocellular carcinoma, human). In the first experiment, cells were co-treated with ALA (100 mu M) and FX (0-100 mu M) or vehicle for 48 h. FX increased eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3), DHA at concentrations of a parts per thousand yen50 mu M. To clarify the change in the metabolism of polyunsaturated fatty acid (PUFA), in the second experiment, cells were co-treated with universally-[C-13]-labeled (U-[C-13]-) ALA (100 mu M) and FX (100 mu M) for 0.5, 3, 6, 24 and 48 h. [C-13] labeled-EPA, DPA and DHA content in HepG2 cells were all increased by FX after 48 h treatment. Furthermore, estimated delta-5 desaturase (D5D) but not delta-6 desaturase (D6D) activity index was increased at 48 h. These results suggested that FX may enhance the conversion of ALA to longer chain n-3 PUFA through increasing D5D activity in the liver.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据